 |
|
Metoclopramide-Induced Neuroleptic Malignant Syndrome
Lawrence S. Friedman, MD;
Larry A. Weinrauch, MD;
John A. D'Elia, MD
Arch Intern Med. 1987;147(8):1495-1497.
Abstract
• The neuroleptic malignant syndrome (NMS), an unusual idiosyncratic reaction to neuroleptic medications, may be fatal If unrecognized. Symptoms of NMS include rigidity, hyperpyrexia, altered consciousness, and autonomic instability. This syndrome is generally associated with neuroleptic medications used to treat psychotic and major depressive illnesses. We describe two diabetic patients at our institution who developed NMS in association with the antiemetic metoclopramide hydrochloride.
(Arch Intern Med 1987;147:1495-1497)
Author Affiliations
From the Department of Internal Medicine, New England Deaconess Hospital, John Cook Renal Unit, Joslin Diabetes Center, Harvard Medical School, Boston.
Footnotes
Accepted for publication May 14, 1987.
Reprint requests to Division of General Internal Medicine, LMOB-7H, New England Deaconess Hospital, 185 Pilgrim Rd, Boston, MA 02215 (Dr Friedman).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Paroxysmal Autonomic Instability With Dystonia After Brain Injury
Blackman et al.
Arch Neurol 2004;61:321-328.
ABSTRACT
| FULL TEXT
Risk of Tardive Dyskinesia in Older Patients: A Prospective Longitudinal Study of 266 Outpatients
Jeste et al.
Arch Gen Psychiatry 1995;52:756-765.
ABSTRACT
Neuroleptic Malignant Syndrome: Review of Response to Therapy
Rosenberg and Green
Arch Intern Med 1989;149:1927-1931.
ABSTRACT
Neuroleptic Malignant Syndrome in a Child Treated With Metoclopramide for Chemotherapy-Related Nausea
Brower et al.
J Child Neurol 1989;4:230-232.
|
